Dynamic imaging approaches will be essential to track amino acid amounts inside tumors as well as the “deorphanization” of the plasma membrane transporters responsible for the import and export of the KP metabolites that can represent valuable alternative targets to inhibit IDO1+ tumor cells or tumor-infiltrating myeloid cells. The gene discussed is IDO1; the disease is neoplasm.